UBS Group AG - PASSAGE BIO INC ownership

PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 86 filers reported holding PASSAGE BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PASSAGE BIO INC
ValueSharesWeighting
Q4 2022$2,430
-83.8%
1,761
-85.1%
0.00%
Q3 2022$15,000
+275.0%
11,849
+760.5%
0.00%
Q1 2022$4,000
-97.0%
1,377
-93.5%
0.00%
Q4 2021$134,000
+1118.2%
21,123
+1872.3%
0.00%
Q3 2021$11,000
-89.2%
1,071
-86.1%
0.00%
Q2 2021$102,000
-85.9%
7,690
-81.5%
0.00%
Q1 2021$725,000
+1379.6%
41,464
+2061.8%
0.00%
Q4 2020$49,000
-61.1%
1,918
-58.4%
0.00%
Q2 2020$126,0004,6130.00%
Other shareholders
PASSAGE BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,959,769$6,844,48114.16%
Lynx1 Capital Management LP 3,355,917$4,631,1654.00%
New Leaf Venture Partners, L.L.C. 2,497,922$3,447,1322.50%
BML Capital Management, LLC 337,467$465,7040.44%
Frazier Life Sciences Management, L.P. 3,756,915$5,184,5430.32%
Orbimed Advisors 8,931,999$12,326,1590.24%
Newtyn Management, LLC 790,000$1,090,2000.22%
Oasis Management Co Ltd. 240,000$331,2000.07%
Rubric Capital Management LP 822,105$1,134,5050.05%
Marquette Asset Management, LLC 67,101$92,5990.03%
View complete list of PASSAGE BIO INC shareholders